FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Valsartan Tablets
Status: Discontinuation
»Therapeutic Categories: Cardiovascular

Expand all

Teva Pharmaceuticals (New 08/03/2018)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
Valsartan Tablets, USP 40mg, 30 count, (NDC 0591-2167-30) 08/03/2018 This was a business-related decision to discontinue manufacturing these products.
Valsartan Tablets, USP 40mg, 90 count, (NDC 0591-2167-19) 08/03/2018 This was a business-related decision to discontinue manufacturing these products.
Valsartan Tablets, USP 80mg, 90 count, (NDC 0591-2168-19) 08/03/2018 This was a business-related decision to discontinue manufacturing these products.
Valsartan Tablets, USP 80mg, 1000 count, (NDC 0591-2168-10) 08/03/2018 This was a business-related decision to discontinue manufacturing these products.
Valsartan Tablets, USP 160mg, 90 count, (NDC 0591-2169-19) 08/03/2018 This was a business-related decision to discontinue manufacturing these products.
Valsartan Tablets, USP 160mg, 1000 count, (NDC 0591-2169-10) 08/03/2018 This was a business-related decision to discontinue manufacturing these products.
Valsartan Tablets, USP 320mg, 90 count, (NDC 0591-2170-19) 08/03/2018 This was a business-related decision to discontinue manufacturing these products.
Valsartan Tablets, USP 320mg, 500 count, (NDC 0591-2170-05) 08/03/2018 This was a business-related decision to discontinue manufacturing these products.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English